国药股份

- 600511

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2024  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014 
国药股份(600511) 利润表
单位:万元
报表日期2024-03-312023-12-312023-09-302023-06-302023-03-31
一、营业总收入1,212,214.264,969,604.553,652,966.682,414,017.571,122,630.18
营业收入1,212,214.264,969,604.553,652,966.682,414,017.571,122,630.18
二、营业总成本1,158,400.504,719,408.893,480,263.462,300,825.271,072,171.05
营业成本1,127,005.584,570,477.613,370,207.692,227,414.501,036,181.10
营业税金及附加2,682.2011,473.608,101.194,602.122,282.37
销售费用20,145.4596,237.8368,154.8747,451.1623,803.29
管理费用10,053.4046,712.7930,798.3020,160.9510,522.14
财务费用-2,880.28-12,612.67-2,315.64-2,237.20-2,286.32
研发费用1,394.167,119.745,317.063,433.741,668.47
资产减值损失----------
公允价值变动收益--1,081.753,472.513,472.51--
投资收益10,497.8735,895.1828,697.6819,745.238,067.42
其中:对联营企业和合营企业的投资收益10,218.6145,653.8732,918.9422,103.588,645.96
汇兑收益----------
三、营业利润61,379.88294,435.78199,380.07132,300.5857,352.32
加:营业外收入62.99300.55292.71186.8087.81
减:营业外支出89.231,647.311,067.3936.5630.85
其中:非流动资产处置损失----------
四、利润总额61,353.65293,089.02198,605.39132,450.8257,409.29
减:所得税费用11,841.8059,641.9540,414.3126,183.1512,366.41
五、净利润49,511.85233,447.07158,191.09106,267.6845,042.87
归属于母公司所有者的净利润45,945.45214,599.87146,229.5998,458.3241,442.86
少数股东损益3,566.3918,847.2011,961.507,809.363,600.01
六、每股收益
基本每股收益(元/股)0.60892.84431.93811.30490.5493
稀释每股收益(元/股)0.60892.84431.93811.30490.5493
七、其他综合收益-585.32510.26101.3175.98408.04
八、综合收益总额48,926.52233,957.34158,292.39106,343.6545,450.91
归属于母公司所有者的综合收益总额45,360.13215,110.14146,330.8998,534.3041,850.90
归属于少数股东的综合收益总额3,566.3918,847.2011,961.507,809.363,600.01
下载全部历史数据到excel中 返回页顶